Literature DB >> 22847727

Predictors of community functioning in schizophrenia and substance use disorder patients.

Simon Zhornitsky1, Ginette Aubin, Joelle Desfossés, Elie Rizkallah, Tania Pampoulova, Olivier Lipp, Jean-Pierre Chiasson, Emmanuel Stip, Stéphane Potvin.   

Abstract

Community functioning is a broad term that encompasses various 'real world' measures of disability among schizophrenia patients. It includes outcomes such as independent living, social competence and behavioural problems-all of which are priorities for treatment among schizophrenia patients, mental health care providers, and family members. An important goal for rehabilitation programs is to identify predictors of community functioning which, in turn, could be used as targets for intervention. The present case-control study examined socio-demographic and substance use disorder (SUD) variables as well as psychiatric, extrapyramidal, and cognitive symptoms as predictors of community functioning in schizophrenia patients with (DD patients; n=31) and without comorbid SUDs (SCZ patients; n=31), and non-psychosis substance abusers (SUD patients; n=39). Psychiatric and extrapyramidal symptoms were evaluated with the Positive and Negative Syndrome Scale, the Calgary Depression Scale for Schizophrenia and the Extrapyramidal Symptoms Rating Scale. Cognition was evaluated using the Cambridge Neuropsychological Test Automated Battery (speed of processing, explicit and working memory). In SCZ patients, community functioning was predicted by explicit memory performance. In DD patients, community functioning was predicted by substance abuse, depression and speed of processing. In SUD patients, community functioning was predicted by substance abuse, positive symptoms and education. Our results suggest that cognition should be among the top treatment priorities in SCZ patients, whereas the key treatment targets in DD patients should be substance abuse and depression. Future studies will need to replicate the current findings, using prospective research designs.

Entities:  

Mesh:

Year:  2012        PMID: 22847727     DOI: 10.1007/s10597-012-9525-y

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  45 in total

Review 1.  Review on vocational predictors: a systematic review of predictors of vocational outcomes among individuals with schizophrenia: an update since 1998.

Authors:  Hector W H Tsang; Ada Y Leung; Raymond C K Chung; Morris Bell; Wai-Ming Cheung
Journal:  Aust N Z J Psychiatry       Date:  2010-06       Impact factor: 5.744

Review 2.  Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB.

Authors:  Marie-Noëlle Levaux; Stéphane Potvin; Amir Ali Sepehry; Juliette Sablier; Adrianna Mendrek; Emmanuel Stip
Journal:  Eur Psychiatry       Date:  2007-01-16       Impact factor: 5.361

3.  The detection of neurocognitive decline in schizophrenia using the Mindstreams Computerized Cognitive Test Battery.

Authors:  Michael S Ritsner; Haya Blumenkrantz; Tatiana Dubinsky; Tzvi Dwolatzky
Journal:  Schizophr Res       Date:  2005-12-27       Impact factor: 4.939

Review 4.  The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis.

Authors:  Anne-Kathrin J Fett; Wolfgang Viechtbauer; Maria-de-Gracia Dominguez; David L Penn; Jim van Os; Lydia Krabbendam
Journal:  Neurosci Biobehav Rev       Date:  2010-07-08       Impact factor: 8.989

5.  Neuropsychological deficits associated with cannabis use in young adults.

Authors:  Jon E Grant; Samuel R Chamberlain; Liana Schreiber; Brian L Odlaug
Journal:  Drug Alcohol Depend       Date:  2011-09-14       Impact factor: 4.492

6.  Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder.

Authors:  S Potvin; T Pampoulova; A Mancini-Marië; O Lipp; R-H Bouchard; E Stip
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06       Impact factor: 10.154

7.  Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users.

Authors:  Kely Lapworth; Sharon Dawe; Penelope Davis; David Kavanagh; Ross Young; John Saunders
Journal:  Addict Behav       Date:  2008-11-24       Impact factor: 3.913

8.  Two weeks' quetiapine treatment for schizophrenia, drug-induced psychosis and borderline personality disorder: a naturalistic study with drug plasma levels.

Authors:  Massimo C Mauri; Lucia S Volonteri; Alessio Fiorentini; Rodolfo Pirola; Silvio R Bareggi
Journal:  Expert Opin Pharmacother       Date:  2007-10       Impact factor: 3.889

Review 9.  Clinical aspects of substance abuse in persons with schizophrenia.

Authors:  Juan C Negrete
Journal:  Can J Psychiatry       Date:  2003-02       Impact factor: 4.356

10.  Cocaine is a major risk factor for antipsychotic induced akathisia, parkinsonism and dyskinesia.

Authors:  Arija Maat; Annemarie Fouwels; Lieuwe de Haan
Journal:  Psychopharmacol Bull       Date:  2008
View more
  3 in total

1.  Predictors of Mental Health Recovery in Homeless Adults with Mental Illness.

Authors:  Nick Kerman; John Sylvestre; Tim Aubry; Jino Distasio; Christian G Schütz
Journal:  Community Ment Health J       Date:  2018-12-05

2.  Factors Associated with Changes in Community Ability and Recovery After Psychiatric Rehabilitation: A Retrospective Study.

Authors:  Bhing-Leet Tan; Wai-Yee Ng; Jayson Sudhasan; Thomas Chng; Irene Mok; Jimmy Lee
Journal:  Community Ment Health J       Date:  2018-02-26

3.  Interpersonal Risk Factors for Suicide in Cocaine Dependence: Association with Self-Esteem, Personality Traits, and Childhood Abuse.

Authors:  Simon Zhornitsky; Thang M Le; Isha Dhingra; Brendan D Adkinson; Stephane Potvin; Chiang-Shan R Li
Journal:  Suicide Life Threat Behav       Date:  2020-02-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.